Cargando…
Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease
BACKGROUND: The aim of this study was to assess the functional and oncologic outcomes of percutaneous radiofrequency ablation (RFA) with contrast-enhanced ultrasonography (CEUS) for renal cell carcinoma in patient with autosomal dominant polycystic kidney. METHODS: We performed a retrospective revie...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962510/ https://www.ncbi.nlm.nih.gov/pubmed/27460786 http://dx.doi.org/10.1186/s12957-016-0916-3 |
_version_ | 1782444851929808896 |
---|---|
author | Xu, Linfeng Rong, Yang Wang, Wei Lian, Huibo Gan, Weidong Yan, Xiang Li, Xiaogong Guo, Hongqian |
author_facet | Xu, Linfeng Rong, Yang Wang, Wei Lian, Huibo Gan, Weidong Yan, Xiang Li, Xiaogong Guo, Hongqian |
author_sort | Xu, Linfeng |
collection | PubMed |
description | BACKGROUND: The aim of this study was to assess the functional and oncologic outcomes of percutaneous radiofrequency ablation (RFA) with contrast-enhanced ultrasonography (CEUS) for renal cell carcinoma in patient with autosomal dominant polycystic kidney. METHODS: We performed a retrospective review of five patients with renal cell carcinoma (RCC) in autosomal dominant polycystic kidney disease (ADPKD) from January 2009 to December 2014 with a media follow-up of 33 months. The tumors were ablated with Cool-tip RFA system under the guidance of CEUS. Routine follow-up included contrast-enhanced computed tomography/magnetic resonance imaging (CT/MRI) and renal function tests. RESULTS: Media diameter of the treated renal tumors was 3.1 cm (range 1.7–5.2 cm). Initial ablation success rate was 4/5. After over 6 months contrast-enhanced CT/MRI follow-up after RFA, no patients experienced local tumor recurrence. No patients required dialysis in the periprocedural period. Minor complications only developed in two cases. There was no significant difference in estimated glomerular filtration rate (eGFR) between pre- and post-RFA. CONCLUSIONS: Our initial experience of this technique for RCC in ADPKD was favorable with good renal function preservation and oncologic outcomes. It may be a good choice for RCC in ADPKD. |
format | Online Article Text |
id | pubmed-4962510 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49625102016-07-28 Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease Xu, Linfeng Rong, Yang Wang, Wei Lian, Huibo Gan, Weidong Yan, Xiang Li, Xiaogong Guo, Hongqian World J Surg Oncol Research BACKGROUND: The aim of this study was to assess the functional and oncologic outcomes of percutaneous radiofrequency ablation (RFA) with contrast-enhanced ultrasonography (CEUS) for renal cell carcinoma in patient with autosomal dominant polycystic kidney. METHODS: We performed a retrospective review of five patients with renal cell carcinoma (RCC) in autosomal dominant polycystic kidney disease (ADPKD) from January 2009 to December 2014 with a media follow-up of 33 months. The tumors were ablated with Cool-tip RFA system under the guidance of CEUS. Routine follow-up included contrast-enhanced computed tomography/magnetic resonance imaging (CT/MRI) and renal function tests. RESULTS: Media diameter of the treated renal tumors was 3.1 cm (range 1.7–5.2 cm). Initial ablation success rate was 4/5. After over 6 months contrast-enhanced CT/MRI follow-up after RFA, no patients experienced local tumor recurrence. No patients required dialysis in the periprocedural period. Minor complications only developed in two cases. There was no significant difference in estimated glomerular filtration rate (eGFR) between pre- and post-RFA. CONCLUSIONS: Our initial experience of this technique for RCC in ADPKD was favorable with good renal function preservation and oncologic outcomes. It may be a good choice for RCC in ADPKD. BioMed Central 2016-07-26 /pmc/articles/PMC4962510/ /pubmed/27460786 http://dx.doi.org/10.1186/s12957-016-0916-3 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Xu, Linfeng Rong, Yang Wang, Wei Lian, Huibo Gan, Weidong Yan, Xiang Li, Xiaogong Guo, Hongqian Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease |
title | Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease |
title_full | Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease |
title_fullStr | Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease |
title_full_unstemmed | Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease |
title_short | Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease |
title_sort | percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962510/ https://www.ncbi.nlm.nih.gov/pubmed/27460786 http://dx.doi.org/10.1186/s12957-016-0916-3 |
work_keys_str_mv | AT xulinfeng percutaneousradiofrequencyablationwithcontrastenhancedultrasonographyforsolitaryandsporadicrenalcellcarcinomainpatientswithautosomaldominantpolycystickidneydisease AT rongyang percutaneousradiofrequencyablationwithcontrastenhancedultrasonographyforsolitaryandsporadicrenalcellcarcinomainpatientswithautosomaldominantpolycystickidneydisease AT wangwei percutaneousradiofrequencyablationwithcontrastenhancedultrasonographyforsolitaryandsporadicrenalcellcarcinomainpatientswithautosomaldominantpolycystickidneydisease AT lianhuibo percutaneousradiofrequencyablationwithcontrastenhancedultrasonographyforsolitaryandsporadicrenalcellcarcinomainpatientswithautosomaldominantpolycystickidneydisease AT ganweidong percutaneousradiofrequencyablationwithcontrastenhancedultrasonographyforsolitaryandsporadicrenalcellcarcinomainpatientswithautosomaldominantpolycystickidneydisease AT yanxiang percutaneousradiofrequencyablationwithcontrastenhancedultrasonographyforsolitaryandsporadicrenalcellcarcinomainpatientswithautosomaldominantpolycystickidneydisease AT lixiaogong percutaneousradiofrequencyablationwithcontrastenhancedultrasonographyforsolitaryandsporadicrenalcellcarcinomainpatientswithautosomaldominantpolycystickidneydisease AT guohongqian percutaneousradiofrequencyablationwithcontrastenhancedultrasonographyforsolitaryandsporadicrenalcellcarcinomainpatientswithautosomaldominantpolycystickidneydisease |